Ackman: Pharma Is Prime to Benefit Shareholders

Ackman: Pharma Is Prime to Benefit Shareholders Play

April 23 (Bloomberg) -- Bill Ackman, CEO at Pershing Square Capital and Michael Pearson, Chairman/CEO at Valeant Pharmaceuticals, discuss the value of the Valeant and Allergan deal to shareholders on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)

  • On Air Now

    The Year Ahead: Innovation Watch Now

  • Next

    The Great Disrupters: Businessweek Anniversary

blog comments powered by Disqus